Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

6VVU

Anti-Tryptase fab E104.v1 bound to tryptase

Summary for 6VVU
Entry DOI10.2210/pdb6vvu/pdb
DescriptorTryptase alpha/beta-1, Fab E104.v1 heavy chain, Fab E104.v1 light chain, ... (6 entities in total)
Functional Keywordsfab, inhibitor, tryptase, immune system, hydrolase-immune system complex, hydrolase/immune system
Biological sourceHomo sapiens (Human)
More
Total number of polymer chains12
Total formula weight315233.71
Authors
Ultsch, M.,Koerber, J.T. (deposition date: 2020-02-18, release date: 2020-12-30, Last modification date: 2024-11-06)
Primary citationMaun, H.R.,Vij, R.,Walters, B.T.,Morando, A.,Jackman, J.K.,Wu, P.,Estevez, A.,Chen, X.,Franke, Y.,Lipari, M.T.,Dennis, M.S.,Kirchhofer, D.,Ciferri, C.,Loyet, K.M.,Yi, T.,Eigenbrot, C.,Lazarus, R.A.,Koerber, J.T.
Bivalent antibody pliers inhibit beta-tryptase by an allosteric mechanism dependent on the IgG hinge.
Nat Commun, 11:6435-6435, 2020
Cited by
PubMed Abstract: Human β-tryptase, a tetrameric trypsin-like serine protease, is an important mediator of allergic inflammatory responses in asthma. Antibodies generally inhibit proteases by blocking substrate access by binding to active sites or exosites or by allosteric modulation. The bivalency of IgG antibodies can increase potency via avidity, but has never been described as essential for activity. Here we report an inhibitory anti-tryptase IgG antibody with a bivalency-driven mechanism of action. Using biochemical and structural data, we determine that four Fabs simultaneously occupy four exosites on the β-tryptase tetramer, inducing allosteric changes at the small interface. In the presence of heparin, the monovalent Fab shows essentially no inhibition, whereas the bivalent IgG fully inhibits β-tryptase activity in a hinge-dependent manner. Our results suggest a model where the bivalent IgG acts akin to molecular pliers, pulling the tetramer apart into inactive β-tryptase monomers, and may provide an alternative strategy for antibody engineering.
PubMed: 33353951
DOI: 10.1038/s41467-020-20143-x
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (3 Å)
Structure validation

227344

건을2024-11-13부터공개중

PDB statisticsPDBj update infoContact PDBjnumon